Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-17
DOI
10.1038/s41598-022-14194-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
- (2022) Mohammad Afsar et al. eLife
- Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
- (2021) Jing-wen Lin et al. Cell Host & Microbe
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
- (2021) Tanuj Sharma et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
- (2021) Ke Zhang et al. Science Advances
- Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
- (2021) Rui Wang et al. GENOMICS
- SARS-CoV-2 non-structural protein 1 inhibits the interferon response by causing depletion of key host signaling factors.
- (2021) Anil Kumar et al. JOURNAL OF VIROLOGY
- Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- (2021) Amit Kumawat et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
- (2021) Christine Vazquez et al. PLoS One
- The total number and mass of SARS-CoV-2 virions
- (2021) Ron Sender et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block
- (2021) James M. Burke et al. RNA
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug
- (2021) Fuad Ameen et al. Journal of Infection and Public Health
- Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity
- (2021) Hin Chu et al. Science Advances
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topical collection on Chromatin Biology and Epigenetics
- (2020) Geeta Narlikar et al. JOURNAL OF BIOSCIENCES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The Architecture of SARS-CoV-2 Transcriptome
- (2020) Dongwan Kim et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)
- (2020) Gabriela de Lima Menezes et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
- (2020) Dennis C. Copertino et al. JOURNAL OF MEDICAL VIROLOGY
- Machine learning classification can reduce false positives in structure-based virtual screening
- (2020) Yusuf O. Adeshina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
- (2020) Katharina Schubert et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
- (2020) Allan Sauvat et al. Cell Death & Disease
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- Structure of nonstructural protein 1 from SARS-CoV-2.
- (2020) Lauren K. Clark et al. JOURNAL OF VIROLOGY
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
- (2020) Shuai Yuan et al. MOLECULAR CELL
- Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2
- (2020) Ryan M. Hekman et al. MOLECULAR CELL
- Structural characterization of nonstructural protein 1 from SARS-CoV-2
- (2020) Cameron Semper et al. iScience
- Simple Determination of Plasma Ponatinib Concentration Using HPLC
- (2018) Takeo Yasu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach
- (2017) Polo C.-H. Lam et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA
- (2017) Yutaka Terada et al. VIROLOGY
- Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals
- (2016) Manel Aouri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression
- (2015) Krishna Narayanan et al. VIRUS RESEARCH
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- Identification of Residues of SARS-CoV nsp1 That Differentially Affect Inhibition of Gene Expression and Antiviral Signaling
- (2013) Andrew R. Jauregui et al. PLoS One
- e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design
- (2012) Emilie Pihan et al. BIOINFORMATICS
- Docking and scoring with ICM: the benchmarking results and strategies for improvement
- (2012) Marco A. C. Neves et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA
- (2012) T. Tanaka et al. JOURNAL OF VIROLOGY
- Structure-based drug screening for G-protein-coupled receptors
- (2012) Brian K. Shoichet et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SARS Coronavirus nsp1 Protein Induces Template-Dependent Endonucleolytic Cleavage of mRNAs: Viral mRNAs Are Resistant to nsp1-Induced RNA Cleavage
- (2011) Cheng Huang et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now